Population-based observational study of claudication in older men: The health in men study

Medical Journal of Australia

Volumn 192, Issue 11, 2010, Pages 641-645

  Lakshmanan, Rahul ^a   Hyde, Zoë ^b   Jamrozik, Konrad ^c   Hankey, Graeme J ^d   Norman, Paul E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLAUDICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SMOKING;

EID: 77953519384     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03663.x     Document Type: Article

References (24)

1. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114: 688-699. (Pubitemid 44252311)
2. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197-208.
3. Beckman JA, Jaff MR, Creager MA. The United States Preventive Services Task Force recommendation statement on screening for peripheral arterial disease. More harm than benefit? Circulation 2006; 114: 861-866.
4. Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham study. Am Heart J 2002; 143: 961-965. (Pubitemid 34666884)
5. Cassar K, Coull R, Bachoo P, et al. Management of secondary risk factors in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2003; 26: 262-266. (Pubitemid 37021365)
6. Rehring TF, Sandhoff BG, Stolcpart RS, et al. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg 2005; 41: 816-822. (Pubitemid 40693804)
7. Selvin E, Hirsch AT. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis 2008; 201: 425-433.
8. Cacoub PP, Abola MTB, Baumgartner I, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009; 204: e86-e92.
9. Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 1994; 72: 128-132. (Pubitemid 24251462)
10. Bowlin SJ, Medalie JH, Flocke SA, et al. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol 1994; 140: 418-430.
11. Leng GC, Lee AJ, Fowkes FGR, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172-1181. (Pubitemid 27013522)
12. Norman PE, Jamrozik K, Lawrence-Brown MM, et al. Population-based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004; 329: 1259-1262. (Pubitemid 39576728)
13. Norman PE, Flicker L, Almeida OP, et al. Cohort profile: the Health in Men Study (HIMS). Int J Epidemiol 2008; 38: 48-52.
14. Leng GC, Fowkes FGR. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101-1109.
15. Norman PE, Le MTQ, Pearce C, Jamrozik K. Infra-renal aortic diameter predicts all-cause mortality. Arterioscler Thromb Vasc Biol 2004; 24: 1278-1282. (Pubitemid 38880021)
16. Fowkes FGR, Housley E, Cawood EHH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-392.
17. Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185-192. (Pubitemid 28277594)
18. Kollerits B, Heinrich J, Pichler M, et al. Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. Atherosclerosis 2008; 198: 214-222.
19. Willgendael EM, Teijink JAW, Bartelink M-L, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004; 40: 1158-1165.
20. Aboyans V, Criqui MH, Denenberg JO, et al. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006; 113: 2623-2629.
21. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease. A meta-analysis of randomised trials. JAMA 2009; 301: 1909-1919.
22. Kannel WB, Skinner Jr JJ, Schwartz MJ, et al. Intermittent claudication. Incidence in the Framingham Study. Circulation 1970; 41: 875-883.
23. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 1990; 82: 1925-1931.
24. Freiberg MS, Arnold AM, Newman AB, et al. Abdominal aortic aneurysms, increasing infrarenal aortic diameter, and risk of total mortality and incident cardiovascular disease events. 10-year follow-up data from the Cardiovascular Health Study. Circulation 2008; 117: 1010-1017.